LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1
Carcinogenesis · 2024
DOI: 10.1093/carcin/bgad097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2024. Verfasst von Cheng Pan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Cell Movement, Cell Proliferation, Disease Progression. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Commission of Health, Program of Jiangsu Medical Innovation Team.
Abstract (Originalsprache)
Long non-coding RNAs (lncRNAs) play crucial roles in the tumorigenesis and progression of lung adenocarcinoma (LUAD). However, little was known about the role of lncRNAs in high-risk LUAD subtypes: micropapillary-predominant adenocarcinoma (MPA) and solid-predominant adenocarcinoma (SPA). In this study, we conducted a systematic screening of differentially expressed lncRNAs using RNA sequencing in 10 paired MPA/SPA tumor tissues and adjacent normal tissues. Consequently, 110 significantly up-regulated lncRNAs and 288 aberrantly down-regulated lncRNAs were identified (|Log2 Foldchange| ≥ 1 and corrected P < 0.05). The top 10 lncRNAs were further analyzed in 89 MPA/SPA tumor tissues and 59 normal tissues from The Cancer Genome Atlas database. Among them, CARD8-AS1 showed the most significant differential expression, and decreased expression of CARD8-AS1 was significantly associated with a poorer prognosis. Functionally, CARD8-AS1 overexpression remarkably suppressed the proliferation, migration and invasion of LUAD cells both in vitro and in vivo. Conversely, inhibition of CARD8-AS1 yielded opposite effects. Mechanistically, CARD8-AS1 acted as a scaffold to facilitate the interaction between TXNRD1 and E3 ubiquitin ligase TRIM25, thereby promoting the degradation of TXNRD1 through the ubiquitin–proteasome pathway. Additionally, TXNRD1 was found to promote LUAD cell proliferation, migration and invasion in vitro. Furthermore, the suppressed progression of LUAD cells resulting from CARD8-AS1 overexpression could be significantly reversed by simultaneous overexpression of TXNRD1. In conclusion, this study revealed that the lncRNA CARD8-AS1 played a suppressive role in the progression of LUAD by enhancing TRIM25-mediated ubiquitination of TXNRD1. The CARD8-AS1-TRIM25-TXNRD1 axis may represent a promising therapeutic target for LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
ORCID-Profile: Liang Chen, Zhihua Li
Förderung
- National Natural Science Foundation of China
- Jiangsu Commission of Health
- Program of Jiangsu Medical Innovation Team
Zitieren
APA
Pan, C., Wang, Q., Wang, H., Deng, X., Chen, L., & Li, Z. (2024). LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1. Carcinogenesis. https://doi.org/10.1093/carcin/bgad097
Vancouver
Pan C, Wang Q, Wang H, Deng X, Chen L, Li Z. LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1. Carcinogenesis. 2024. doi:10.1093/carcin/bgad097
BibTeX
@article{Pan2024,
author = {Pan, Cheng and Wang, Qi and Wang, Hongshun and Deng, Xiaheng and Chen, Liang and Li, Zhihua},
title = {LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1},
journal = {Carcinogenesis},
year = {2024},
doi = {10.1093/carcin/bgad097}
}
EUVIMED